Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADX-629 in Moderate Alcohol Associated Hepatitis
NCT06685692Phase 2Completed
- Sponsor
- Aldeyra Therapeutics
- Start
- Nov 2024
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of acloproxalap in alcoholic hepatitis (AH), sponsored by Aldeyra Therapeutics. Started Nov 2024; status: completed.
02
Drugs
acloproxalap
03
Conditions
alcoholic hepatitis (AH)
Beyond the preview
Go deeper on NCT06685692.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06685692.